McNeill Baur, PLLC
Anti-Siglec-9 antibodies and methods of use thereof
The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a Siglec-9 protein, e.g., human Siglec-9 or a mammalian Siglec-9, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
ALECTOR LLC
C A A C C A C C C A C A C A A
C07K A61P A61P C07K C07K A61P C07K C07K C07K A61K C07K A61P C07K A61K A61K
additional inventional inventional additional additional inventional inventional additional additional inventional additional inventional additional additional inventional
Kate Seung-Joo Arnon
Monroe Lee Rosenthal